English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech Healthcare & Pharm
Cielo Maintains No. 1 Global Ranking on 2021 HRO Today's RPO Baker's Dozen
Sep 22, 2021 09:00 HKT
Cielo Maintains No. 1 Global Ranking on 2021 HRO Today's RPO Baker's Dozen
Sep 22, 2021 09:00 HKT
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
Sep 21, 2021 12:00 HKT
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
Sep 21, 2021 12:00 HKT
中国抗体、信诺维与云顶新耀宣布签署新一代BTK抑制剂SN1011肾病领域的全球开发及商业化的授权协议
Sep 17, 2021 08:42 HKT
中國抗體、信諾維與雲頂新耀宣佈簽署新一代BTK抑制劑SN1011腎病領域的全球開發及商業化的授權協議
Sep 17, 2021 08:41 HKT
SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases
Sep 17, 2021 08:40 HKT
和铂医药-B(02142.HK)公布HBM4003临床I期数据,突显疗效及安全性优势
Sep 16, 2021 15:31 HKT
和鉑醫藥-B(02142.HK)公佈HBM4003臨床I期數據,突顯療效及安全性優勢
Sep 16, 2021 15:30 HKT
多元化产品剑指生物疗法宏伟蓝图 创胜集团招股反响热烈
Sep 16, 2021 11:13 HKT
多元化產品劍指生物療法宏偉藍圖 創勝集團招股反響熱烈
Sep 16, 2021 11:12 HKT
华领医药与国药控股签署供应链战略合作协议 加速商业化布局
Sep 15, 2021 14:37 HKT
華領醫藥與國藥控股簽署供應鏈戰略合作協議 加速商業化佈局
Sep 15, 2021 14:36 HKT
Hua and Sinopharm Announced Supply Chain Strategic Cooperation
Sep 15, 2021 14:35 HKT
创胜集团今日正式招股 礼来亚洲基金、淡马锡等明星股东强力加持
Sep 14, 2021 15:03 HKT
創勝集團今日正式招股 禮來亞洲基金、淡馬錫等明星股東強力加持
Sep 14, 2021 15:02 HKT
创胜集团即将在港招股 在研产品覆盖肿瘤、骨科和肾病领域 明星资本力捧或成一匹黑马
Sep 14, 2021 14:57 HKT
創勝集團即將在港招股 在研產品覆蓋腫瘤、骨科和腎病領域 明星資本力捧或成一匹黑馬
Sep 14, 2021 14:56 HKT
Legend Capital Led a New Round of Investment of Etana
Sep 14, 2021 08:42 HKT
미 FDA, 휴머니젠의 코로나19 환자용 치료제 렌질루맙 긴급사용승인(EUA) 거부
Sep 13, 2021 11:00 HKT
Next >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: